165 related articles for article (PubMed ID: 4147836)
1. Potential bioreductive alkylating agents. 2. Antitumor effect and biochemical studies of naphthoquinone derivatives.
Lin AJ; Pardini RS; Cosby LA; Lillis BJ; Shansky CW; Sartorelli AC
J Med Chem; 1973 Nov; 16(11):1268-71. PubMed ID: 4147836
[No Abstract] [Full Text] [Related]
2. Potential bioreductive alkylating agents. 4. Inhibition of coenzyme Q enzyme systems by lipoidal benzoquinone and naphthoquinone derivatives.
Lin AJ; Pardini RS; Lillis BJ; Sartorelli AC
J Med Chem; 1974 Jul; 17(7):688-7. PubMed ID: 4151966
[No Abstract] [Full Text] [Related]
3. Potential bioreductive alkylating agents. 1. Benzoquinone derivatives.
Lin AJ; Cosby LA; Shansky CW; Sartorelli AC
J Med Chem; 1972 Dec; 15(12):1247-52. PubMed ID: 4635968
[No Abstract] [Full Text] [Related]
4. 2- and 6-methyl-1,4-naphthoquinone derivatives and potential bioreductive alkylating agents.
Antonini I; Lin TS; Cosby LA; Dai YR; Sartorelli AC
J Med Chem; 1982 Jun; 25(6):730-5. PubMed ID: 7097727
[TBL] [Abstract][Full Text] [Related]
5. Potential bioreductive alkylating agents. 7. Antitumor effects of phenyl-substituted 2-chloromethyl-3-phenyl-1,4-naphthoquinones.
Lin AJ; Sartorelli AC
J Med Chem; 1976 Nov; 19(11):1336-8. PubMed ID: 1003413
[TBL] [Abstract][Full Text] [Related]
6. Potential bioreductive alkylating agents. 3. Synthesis and antineoplastic activity of acetoxymethyl and corresponding ethyl carbamate derivatives of benzoquinones.
Lin AJ; Shansky CW; Sartorelli AC
J Med Chem; 1974 May; 17(5):558-61. PubMed ID: 4830263
[No Abstract] [Full Text] [Related]
7. Quinones as anticancer agents: potential bioreductive alkylating agents.
Lin AJ; Coby LA; Sartorelli AC
Cancer Chemother Rep 2; 1974 Dec; 4(4):23-5. PubMed ID: 4155656
[No Abstract] [Full Text] [Related]
8. Potential bioreductive alkylating agents. 5. Antineoplastic activity of quinoline-5,8-diones, naphthazarins, and naphthoquinones.
Lin AJ; Lillis BJ; Sartorelli AC
J Med Chem; 1975 Sep; 18(9):917-21. PubMed ID: 1159713
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of the bioreductive alkylating agent, 2,3-bis(chloromethyl)-1,4-naphthoquinone.
Cosby LA; Pardini RS; Biagini RE; Lambert TL; Lin AJ; Huang YM; Hwang KM; Sartorelli AC
Cancer Res; 1976 Nov; 36(11 Pt 1):4023-31. PubMed ID: 184923
[TBL] [Abstract][Full Text] [Related]
10. 2,3-Dimethyl-1,4-naphthoquinone derivatives as bioreductive alkylating agents with cross-linking potential.
Lin TS; Antonini I; Cosby LA; Sartorelli AC
J Med Chem; 1984 Jun; 27(6):813-5. PubMed ID: 6737425
[TBL] [Abstract][Full Text] [Related]
11. [Carcinostasis with heterocyclic derivatives of 2-amino-1,4-naphthoquinone in transplantation-tumors].
Grundmann E; Jühling L; Pütter J; Seidel HJ
Z Krebsforsch; 1969; 72(2):185-96. PubMed ID: 4239416
[No Abstract] [Full Text] [Related]
12. [Derivatives of 2-amino-1,4-naphthoquinone as carcinostatic agents].
Petersen S; Gauss W; Kiehne H; Jühling L
Z Krebsforsch; 1969; 72(2):162-75. PubMed ID: 4239415
[No Abstract] [Full Text] [Related]
13. Naphthazarin derivatives (VII): antitumor action against ICR mice bearing ascitic S-180 cells.
Song GY; Kim Y; You YJ; Cho H; Ahn BZ
Arch Pharm Res; 2001 Jun; 24(3):190-3. PubMed ID: 11440074
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of two derivatives from 2-acylamine-1, 4-naphthoquinone in mice bearing S180 tumor.
Bezerra DP; Alves AP; de Alencar NM; Mesquita Rde O; Lima MW; Pessoa C; de Moraes MO; Lopes JN; Lopes NP; Costa-Lotufo LV
J Exp Ther Oncol; 2008; 7(2):113-21. PubMed ID: 18771085
[TBL] [Abstract][Full Text] [Related]
15. Potential antitumor agents. 10. Synthesis and biochemical properties of 5-N-alkylamino-,N,N-dialkylamino-, and N-alkylacetamido-1-formylisoquinoline thiosemicarbazones.
Mooney PD; Booth BA; Moore EC; Agrawal KC; Sartorelli AC
J Med Chem; 1974 Nov; 17(11):1145-50. PubMed ID: 4370274
[No Abstract] [Full Text] [Related]
16. Synthesis and evaluation of antitumor activity of novel 1,4-naphthoquinone derivatives (IV).
Kim BH; Yoo J; Park SH; Jung JK; Cho H; Chung Y
Arch Pharm Res; 2006 Feb; 29(2):123-30. PubMed ID: 16526275
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mitochondrial electron transport systems by phosvel and some environmental conversion products.
Winston GW; Pardini R
Bull Environ Contam Toxicol; 1976 Jan; 15(1):19-23. PubMed ID: 58687
[No Abstract] [Full Text] [Related]
18. [Molecular basis of the relation between the cytotoxic effect of antineoplastic compounds and the cell cycle phase].
Belousova AK
Vopr Onkol; 1972; 18(8):88-96. PubMed ID: 4348595
[No Abstract] [Full Text] [Related]
19. 6-(1-alkenoyloxyalkyl)-5,8-dimethoxy-1,4-naphthoquinone derivatives:synthesis and evaluation of antitumor activity.
You YJ; Ahn BZ
Arch Pharm Res; 1998 Dec; 21(6):738-43. PubMed ID: 9868548
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activities of 2,3-dihydro-1,4-benzothiazines, and of their 4-(N-alkyl amides) and 4-(N-alkyl N-nitrosoamides).
Gupta RR; Dev PK; Sharma ML; Rajoria CM; Gupta A; Nyati M
Anticancer Drugs; 1993 Oct; 4(5):589-92. PubMed ID: 8292818
[No Abstract] [Full Text] [Related]
[Next] [New Search]
